Skip to main content
. 2017 Jan 27;8(10):16488–16497. doi: 10.18632/oncotarget.14870

Table 2. Associations and stratification analysis of VEGFA 2578 C/A polymorphism and HCC risk.

Variable Genotypes HCC (%) n = 476 Control (%) n = 526 Adjusted OR (95% CI) P value
Age
< 55 years CC 169 (62.6) 175 (55.9) 1.00
CA + AA 101 (37.4) 138 (44.1) 0.57 (0.38,0.87) 0.009
≥ 55 years CC 132 (64.1) 115 (54.0) 1.00
CA + AA 74 (35.9) 98 (46.0) 0.53 (0.33,0.84) 0.007
Gender
Female CC 76 (61.3) 87 (62.1) 1.00
CA + AA 48 (38.7) 53 (37.9) 1.06 (0.60,1.88) 0.840
Male CC 225 (63.9) 203 (52.6) 1.00
CA + AA 127 (36.1) 183 (47.4) 0.43 (0.29,0.63) 0.000
Smoking
Yes CC 159 (62.1) 97 (54.5) 1.00
CA + AA 97 (37.9) 81 (45.5) 0.61 (0.38,1.00) 0.054
No CC 142 (64.5) 193 (55.5) 1.00
CA + AA 78 (35.5) 155 (44.5) 0.57 (0.38,0.87) 0.008
Drinking
Yes CC 79 (60.8) 71 (57.7) 1.00
CA + AA 51 (39.2) 52 (42.3) 0.61 (0.32,1.18) 0.143
No CC 222 (64.2) 219 (54.3) 1.00
CA + AA 124 (35.8) 184 (45.7) 0.57 (0.40,0.82) 0.002
HBV
HbsAg (+) CC 194 (60.2) 37 (43.5) 1.00
CA + AA 128 (39.8) 48 (56.5) 0.53 (0.32,0.86) 0.011
HbsAg (–) CC 107 (69.5) 253 (57.4) 1.00
CA + AA 47 (30.5) 188 (42.6) 0.60 (0.40,0.89) 0.010
Family history of cancer
Yes CC 29 (64.4) 24 (51.1) 1.00
CA + AA 16 (35.6) 23 (48.9) 0.48 (0.16,1.46) 0.194
No CC 272 (63.1) 266 (55.5) 1.00
CA + AA 159 (36.9) 213 (44.5) 0.56 (0.41,0.77) 0.000